Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net (loss)	$ (5,761)	$ (689)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	587	400
Stock based compensation expense	462	410
Loss on disposal of equipment	0	7
Gain on sale of product line	0	(2,161)
Net change in operating assets and liabilities:
Accounts receivable, net	(724)	(384)
Inventories	(430)	994
Prepaid expenses and other current assets	84	0
Other assets	3	0
Accounts payable	(397)	(1,071)
Accrued payroll and related expenses	174	(17)
Deferred revenue	129	(51)
Other liabilities	(223)	65
Net cash used in operating activities	(6,096)	(2,497)
Cash flows from investing activities:
Capital expenditures	(326)	(342)
Cash acquired in acquisition	351	0
Proceeds from sale of product line	0	2,535
Net cash provided by investing activities	25	2,193
Cash flows from financing activities:
Repayment of related party notes payable	(150)	0
Exercise of options and warrants	21	0
Issuance of common stock	5,944	0
Repurchase of common stock	(68)	(54)
Net cash provided by (used in) financing activities	5,747	(54)
Effects of foreign currency rate changes on cash and cash equivalents	15	0
Net decrease in cash and cash equivalents	(309)	(358)
Cash and cash equivalents at beginning of period	6,884	7,879
Cash and cash equivalents at end of period	6,575	7,521
Supplemental non-cash financing and investing information:
Transfer of inventories to equipment	65	561
Stock issued for repayment of related party note payable	$ 187	$ 0